Strategic Priorities and Outlook for LATAM Healthcare Markets in 2026
On April 8th in São Paulo, FrontierView will host its first Latin America Healthcare Executive Roundtable of 2026: Strategic Priorities and Outlook for Latin American Healthcare Markets. This exclusive, in-person forum will convene senior LATAM & Brazil executives from the pharmaceutical, MedTech, and diagnostics sectors as they navigate structural shifts across the region.
This invitation-only session will be an interactive discussion led by Alec Lee, Managing Director, Global Healthcare, together with FrontierView’s Regional Healthcare and Macroeconomics team. Our goal is to promote a dynamic exchange of insights and deep strategic alignment on the operational challenges and investment priorities in the region for 2026.
Why Participate?
In 2026, Latin America is undergoing a critical rebalancing phase. Governments are pursuing expanded access and hospital modernization, yet tightening fiscal space is constraining public healthcare budgets. Key dynamics include:
- Ambiguous operating environment: Opportunities in specialized care and diagnostics are expanding, while innovative technologies face stricter cost-effectiveness assessments and mounting access barriers across multiple markets.
- Intensifying global competition: The entry of new players and ongoing supply chain reconfiguration are compelling healthcare multinationals to reassess go-to-market models and pricing strategies to ensure long-term resilience.
- Political inflection point: Pivotal elections in Brazil, Peru, and Colombia, alongside Chile’s new government advancing structural healthcare reforms, may significantly reshape regulatory frameworks and the broader investment climate.
Participation is reserved for senior P&L leaders, with attendance intentionally limited to preserve a high-level, peer-only dialogue.
To express interest, please contact Renata Abbud at renata.abbud@fiscalnote.com or select “Request Invitation,” and a member of the FrontierView team will follow up directly.